← Back to all trials
Enrolling By Invitation
NCT05627674
Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
Conditions: Smoking, Smoking Cessation, Tobacco Use Cessation
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 915
Sponsor: Washington University School of Medicine
Location: United States
Summary
This trial tests the effects of two versions of RiskProfile, a clinically-informed and a genetically-informed version of a patient-specific risk feedback tool, in comparison to usual care, on lung cancer screening and tobacco treatment.
The trial assesses the multilevel effects of these precision risk feedback tools on the likelihood of clinicians to order lung cancer screening and tobacco treatment and of their patients to utilize these cancer prevention interventions.
Eligibility Criteria
Inclusion Criteria:CLINICIANS:- Primary care clinician with active caseload in participating clinicsPATIENTS:Patient of participating primary care clinicianLung cancer screening naïveBetween 50 to 80 years of age, inclusiveCurrently smoking or quit within past 15 yearsCumulative pack years ≥ 20English-speakingExclusion Criteria:PATIENTS:Lung cancer diagnosisCurrent order placed for lung cancer screening
Source: ClinicalTrials.gov (NCT05627674). StuddyBuddy aggregates publicly available trial information.
